ObjectivesCisplatin, a widely used chemotherapeutic agent, has serious side effects, including nephrotoxicity and ototoxicity. Minocycline is a semisynthetic second-generation tetracycline that exerts anti-inflammatory and neuroprotective effects. The purpose of this study was to elucidate the protective effect of minocycline against cisplatin-induced ototoxicity in the auditory hair cell.MethodsThe House Ear Institute-Organ of Corti 1 (HEI-OC1) cell line and guinea pigs were used for in vitro and in vivo experiments. Cells were exposed to cisplatin with or without pre-treatment with minocycline. Cell survival was analyzed using MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide). Whole-cell lysates were collected and immunob...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
It has been almost forty years since cisplatin was introduced in clinical practice as a potent and ...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
SummaryCisplatin is an antineoplastic drug for cancer treatment in children and adults. The side eff...
Introduction: Cisplatin is one of the most commonly used antineoplastic drugs; nonetheless, its otot...
SummaryCisplatin is an antineoplastic drug for cancer treatment in children and adults. The side eff...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is widely used for the treatment of a variety of tumors. Unfortunately, the therapeutic ef...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
AbstractCisplatin is a widely used anti-cancer drug. Ototoxicity is a major dose-limiting side-effec...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
It has been almost forty years since cisplatin was introduced in clinical practice as a potent and ...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
It has been almost forty years since cisplatin was introduced in clinical practice as a potent and ...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
SummaryCisplatin is an antineoplastic drug for cancer treatment in children and adults. The side eff...
Introduction: Cisplatin is one of the most commonly used antineoplastic drugs; nonetheless, its otot...
SummaryCisplatin is an antineoplastic drug for cancer treatment in children and adults. The side eff...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
Cisplatin is widely used for the treatment of a variety of tumors. Unfortunately, the therapeutic ef...
Cisplatin is a highly effective chemotherapeutic agent that is widely used to treat solid organ mali...
AbstractCisplatin is a widely used anti-cancer drug. Ototoxicity is a major dose-limiting side-effec...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
It has been almost forty years since cisplatin was introduced in clinical practice as a potent and ...
SummaryCisplatin is a chemotherapy agent frequently used to treat different types of neoplasia. Otot...
Aim: It was aimed to evaluate in-vivo whether darbepoetin-alpha (DPO)application has a preventive ro...
It has been almost forty years since cisplatin was introduced in clinical practice as a potent and ...